Oculis Holding AG OCS
NASDAQ OCS
$8.76 -0.58 (-6.21%)
At close: Oct 1, 2026 · 4:00 PM EDT

Oculis Holding AG (OCS) Net Equity Issued and Repurchased (2022 - 2026)

Updated

Oculis Holding AG (OCS) recorded Net Equity Issued and Repurchased of $121,463 in Q2 2026, down 92.4% from $1.6 million a year earlier and down 80.2% from the prior quarter.

Analysis

Oculis Holding AG (OCS) Net Equity Issued and Repurchased (2022 - 2026) Analysis & Trends

On a TTM basis, Oculis Holding AG's Net Equity Issued and Repurchased came in at $1.05 million as of Jun 30, 2026, down 61.4% year-over-year; for FY2025, it came in at $2.37 million, up 122.5% from FY2024.

  • Annual Net Equity Issued and Repurchased has increased for three straight years, with a three-year compound annual growth rate of 166.2% (FY2022 to FY2025).
  • Across earlier years, Net Equity Issued and Repurchased came in at $1.07 million in FY2024 (+245.2%), $308,895 in FY2023 (+145.6%) and $125,794 in FY2022.
  • Quarterly Net Equity Issued and Repurchased has ranged from -$398,518 in Q3 2023 to $1.6 million in Q2 2025 over the past five years.
  • On a year-over-year basis, Net Equity Issued and Repurchased rose in three of the last six quarters, with growth averaging 22.2%.
  • Per Business Quant, the preceding three quarters came in at $614,239 (Q1 2026), $304,034 (Q4 2025) and $13,751 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 Oculis Holding AG 487.95 Mn 487.95 Mn - 121,462.95
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 121,462.95
Mar 31, 2026 614,239.25
Dec 31, 2025 304,034.26
Sep 30, 2025 13,751.20
Jun 30, 2025 1.60 Mn
Mar 31, 2025 349,246.67
Dec 31, 2024 85,614.14
Sep 30, 2024 693,678.55
Jun 30, 2024 39,808.57
Mar 31, 2024 258,924.20
Dec 31, 2023 148,810.79
Sep 30, 2023 -398,517.70
Dec 31, 2022 8,304.18
API Access

Oculis Holding AG Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=OCS&period=max&api_key=YOUR_API_KEY